Literature DB >> 8094944

Discordant LFA-1/ICAM-1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytoma.

H Tsutani1, T Sugiyama, S Shimizu, H Iwasaki, T Ueda, K Ozaki, S Konda, T Nakamura.   

Abstract

We observed a unique case of multiple myeloma that was transformed into plasma cell leukemia presenting with subcutaneous and soft tissue infiltrates. Subcutaneous and minor pelvic soft tissue plasmacytomas and the leukemic transformation were diagnosed in a 72-year-old woman after she had completed 9 months of chemotherapy for IgG kappa multiple myeloma. Immunophenotypic study revealed that leukemic cells in her peripheral blood were positive for ICAM-1 (CD54) but negative for LFA-1 alpha (CD11a) and LFA-1 beta (CD18), whereas infiltrating leukemic cells in the subcutaneous plasmacytoma of the left thigh were positive for LFA-1 alpha and LFA-1 beta but negative for ICAM-1. In addition, intermingling capillary endothelial cells were positive for ICAM-1. Extramedullary soft tissue plasmacytoma is uncommon in association with plasma cell tumors, and the exact mechanism of the development of plasmacytoma is not known. In the present case, however, the discordant expression of LFA-1/ICAM-1 adhesion molecules may have accounted for the distinct patterns of growth and the spread of the subcutaneous plasmacytoma through homing of the LFA-1 alpha+, LFA-1 beta+ leukemic cells to ICAM-1+ endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094944     DOI: 10.1002/ajh.2830420310

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Radiotherapy for multiple myeloma with skin involvement.

Authors:  S K A Nguyen; A Dagnault
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

2.  Expression of adhesion molecules on myeloma cells.

Authors:  T Tatsumi; C Shimazaki; H Goto; S Araki; Y Sudo; N Yamagata; E Ashihara; T Inaba; N Fujita; M Nakagawa
Journal:  Jpn J Cancer Res       Date:  1996-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.